Fluorescence Guided Surgery System Market
Fluorescence Guided Surgery System Market Size, Share & Trends Analysis Report by Type (SPY System, PDE System, and VS3 Iridium Systems), by Surgery (Open Surgery, and Laparoscopy/Endoscopy), and by Application (Cancer Surgeries, Cardiovascular Surgeries, and Others) Forecast Period (2024-2031)
Fluorescence guided surgery system market is anticipated to grow at a CAGR of 15.7% during the forecast period (2024-2031). Fluorescence-guided surgery (FGS) is an optical imaging technique that uses invisible light to create a real-time image of the surgical area during a procedure. This helps surgeons identify and remove or preserve anatomical features like tumors, cancer cells, and nerves with greater precision and accuracy. FGS can also reduce the risk of damaging healthy tissue, which can shorten the operation and decrease the need for repeat surgeries.
Market Dynamics
A growing number of surgeries
The number of surgical procedures, healthcare spending, and regulatory approvals are all expected to increase, which will drive growth in the global FGS system market. Improved fluorescent probes that are extremely selective to malignant cells or target tissues are the result of research and development. During operations, these probes help doctors see the surgical site more clearly. Clinical evidence demonstrates that FGS improves patient outcomes, which motivates medical facilities to implement it during surgeries.
A rising number of research and development
Research and development activities result in the creation of ever-more-advanced fluorescent probes that are extremely selective to malignant cells or other target tissues. With the use of these probes, doctors can see the surgical site more clearly while performing their procedures. An expanding clinical data collection shows that FGS has improved patient outcomes. The use of these technologies by healthcare facilities is encouraged by these findings.
Market Segmentation
- Based on type, the market is sub-segmented into SPY system, PDE system, and VS3 iridium system.
- Based on surgery, the market is bifurcated into open surgery and laparoscopy/endoscopy.
- Based on application, the market is segmented into cancer surgeries, cardiovascular surgeries, and others (gastrointestinal).
SPY System is Projected to Emerge as the Largest Segment
The growing prevalence of cardiac problems has led to a dominant market for the SPY system, which employs FGS to enhance surgical outcomes. Similar to the SPY system, FGS systems leverage particular biological targets and real-time tissue perfusion monitoring during surgery. With the SPY system, surgeons can perform procedures with minimal difficulties and improve patient outcomes. Hence, these systems hold a major share in the global market.
Regional Outlook
The global fluorescence guided surgery system market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Asia-Pacific countries to serve as a clinical research center
- The Asia-Pacific region serves as a center for clinical research and FGS collaboration, bringing together academic institutions and medical providers to conduct technology development and clinical trials.
- Policies and regulations regarding reimbursement for fluorescence guided procedures differ based on the particular application and healthcare provider across the region.
Global Fluorescence Guided Surgery System Market Growth by Region 2024-2031
North America Holds Major Market Share
The high prevalence of chronic diseases including cancer and cardiovascular disease, as well as the high level of awareness and demand for sophisticated surgical treatments across the region, are the key contributors to the regional market share. Moreover, the advanced healthcare infrastructure of the region along with favorable medical reimbursement policies regarding surgical procedures are likely to drive the regional market growth.
Market Players Outlook
*Note: Major Players Sorted in No Particular Order.
The major companies serving the global fluorescence guided surgery system market include Hamamatsu Photonics K.K., Olympus Corp., Stryker Corp., Medtronic PLC, and Getinge AB, among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market.
The Report Covers
- Market value data analysis of 2023 and forecast to 2031.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global fluorescence guided surgery system market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Hamamatsu Photonics K.K.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Olympus Corp.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Stryker Corp.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Key Strategy Analysis
4. Market Segmentation
4.1. Global Fluorescence Guided Surgery System Market by Type
4.1.1. SPY System
4.1.2. PDE System
4.1.3. VS3 Iridium System
4.2. Global Fluorescence Guided Surgery System Market by Surgery
4.2.1. Open Surgery
4.2.2. Laparoscopy/Endoscopy
4.3. Global Fluorescence Guided Surgery System Market by Application
4.3.1. Cancer Surgeries
4.3.2. Cardiovascular Surgeries
4.3.3. Others (Gastrointestinal Surgery)
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
5.4.1. Latin America
5.4.2. Middle East & Africa
6. Company Profiles
6.1. 3M Company
6.2. B. Braun Melsungen AG
6.3. Becton, Dickinson and Company (BD)
6.4. Boston Scientific Corp.
6.5. CONMED Corp.
6.6. Curadel LLC
6.7. Erbe Elektromedizin Gmbh
6.8. Getinge AB
6.9. Irillic Pvt. Ltd.
6.10. Johnson & Johnson Service, Inc.
6.11. Karl Storz SE & Co. KG
6.12. Medtronic PLC
6.13. OnLume Inc.
6.14. PerkinElmer, Inc.
6.15. Shimadzu Corp.
1. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEM MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
2. GLOBAL FLUORESCENCE GUIDED SURGERY SPY SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
3. GLOBAL FLUORESCENCE GUIDED SURGERY PDE SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
4. GLOBAL FLUORESCENCE GUIDED SURGERY VS3 IRIDIUM SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
5. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEM MARKET RESEARCH AND ANALYSIS BY SURGERY, 2023-2031 ($ MILLION)
6. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEM FOR OPEN SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
7. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEM FOR LAPAROSCOPY/ENDOSCOPY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
8. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
9. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEM FOR CANCER SURGERIES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
10. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEM FOR CARDIOVASCULAR SURGERIES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
11. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEM FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
12. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
13. NORTH AMERICAN FLUORESCENCE GUIDED SURGERY SYSTEM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
14. NORTH AMERICAN FLUORESCENCE GUIDED SURGERY SYSTEM MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
15. NORTH AMERICAN FLUORESCENCE GUIDED SURGERY SYSTEM MARKET RESEARCH AND ANALYSIS BY SURGERY, 2023-2031 ($ MILLION)
16. NORTH AMERICAN FLUORESCENCE GUIDED SURGERY SYSTEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
17. EUROPEAN FLUORESCENCE GUIDED SURGERY SYSTEM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
18. EUROPEAN FLUORESCENCE GUIDED SURGERY SYSTEM MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
19. EUROPEAN FLUORESCENCE GUIDED SURGERY SYSTEM MARKET RESEARCH AND ANALYSIS BY SURGERY, 2023-2031 ($ MILLION)
20. EUROPEAN FLUORESCENCE GUIDED SURGERY SYSTEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
21. ASIA-PACIFIC FLUORESCENCE GUIDED SURGERY SYSTEM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
22. ASIA-PACIFIC FLUORESCENCE GUIDED SURGERY SYSTEM MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
23. ASIA-PACIFIC FLUORESCENCE GUIDED SURGERY SYSTEM MARKET RESEARCH AND ANALYSIS BY SURGERY, 2023-2031 ($ MILLION)
24. ASIA-PACIFIC FLUORESCENCE GUIDED SURGERY SYSTEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
25. REST OF THE WORLD FLUORESCENCE GUIDED SURGERY SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
26. REST OF THE WORLD FLUORESCENCE GUIDED SURGERY SYSTEM MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
27. REST OF THE WORLD FLUORESCENCE GUIDED SURGERY SYSTEM MARKET RESEARCH AND ANALYSIS BY SURGERY, 2023-2031 ($ MILLION)
28. REST OF THE WORLD FLUORESCENCE GUIDED SURGERY SYSTEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
1. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEM MARKET SHARE BY TYPE, 2023 VS 2031 (%)
2. GLOBAL FLUORESCENCE GUIDED SURGERY SPY SYSTEM MARKET SHARE BY REGION, 2023 VS 2031 (%)
3. GLOBAL FLUORESCENCE GUIDED SURGERY PDE SYSTEM MARKET SHARE BY REGION, 2023 VS 2031 (%)
4. GLOBAL FLUORESCENCE GUIDED SURGERY VS3 IRIDIUM SYSTEM MARKET SHARE BY REGION, 2023 VS 2031 (%)
5. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEM MARKET SHARE BY SURGERY, 2023 VS 2031 (%)
6. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEM FOR OPEN SURGERY MARKET SHARE BY REGION, 2023 VS 2031 (%)
7. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEM FOR LAPAROSCOPY/ENDOSCOPY MARKET SHARE BY REGION, 2023 VS 2031 (%)
8. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEM MARKET SHARE BY APPLICATION, 2023 VS 2031 (%)
9. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEM FOR CANCER SURGERIES MARKET SHARE BY REGION, 2023 VS 2031 (%)
10. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEM FOR CARDIOVASCULAR SURGERIES MARKET SHARE BY REGION, 2023 VS 2031 (%)
11. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEM FOR OTHER APPLICATIONS MARKET SHARE BY REGION, 2023 VS 2031 (%)
12. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEM MARKET SHARE BY REGION, 2023 VS 2031 (%)
13. US FLUORESCENCE GUIDED SURGERY SYSTEM MARKET SIZE, 2023-2031 ($ MILLION)
14. CANADA FLUORESCENCE GUIDED SURGERY SYSTEM MARKET SIZE, 2023-2031 ($ MILLION)
15. UK FLUORESCENCE GUIDED SURGERY SYSTEM MARKET SIZE, 2023-2031 ($ MILLION)
16. FRANCE FLUORESCENCE GUIDED SURGERY SYSTEM MARKET SIZE, 2023-2031 ($ MILLION)
17. GERMANY FLUORESCENCE GUIDED SURGERY SYSTEM MARKET SIZE, 2023-2031 ($ MILLION)
18. ITALY FLUORESCENCE GUIDED SURGERY SYSTEM MARKET SIZE, 2023-2031 ($ MILLION)
19. SPAIN FLUORESCENCE GUIDED SURGERY SYSTEM MARKET SIZE, 2023-2031 ($ MILLION)
20. REST OF EUROPE FLUORESCENCE GUIDED SURGERY SYSTEM MARKET SIZE, 2023-2031 ($ MILLION)
21. INDIA FLUORESCENCE GUIDED SURGERY SYSTEM MARKET SIZE, 2023-2031 ($ MILLION)
22. CHINA FLUORESCENCE GUIDED SURGERY SYSTEM MARKET SIZE, 2023-2031 ($ MILLION)
23. JAPAN FLUORESCENCE GUIDED SURGERY SYSTEM MARKET SIZE, 2023-2031 ($ MILLION)
24. SOUTH KOREA FLUORESCENCE GUIDED SURGERY SYSTEM MARKET SIZE, 2023-2031 ($ MILLION)
25. REST OF ASIA-PACIFIC FLUORESCENCE GUIDED SURGERY SYSTEM MARKET SIZE, 2023-2031 ($ MILLION)
26. LATIN AMERICA FLUORESCENCE GUIDED SURGERY SYSTEM MARKET SIZE, 2023-2031 ($ MILLION)
27. MIDDLE EAST AND AFRICA FLUORESCENCE GUIDED SURGERY SYSTEM MARKET SIZE, 2023-2031 ($ MILLION)
